Skip to content

Released May 3, 2023, after the close

10-Q filed May 4, 2023, 34 days after period end · 0001653477-23-000037

Q1 2023 · 10-Q
Revenue$392.60M+2.6% vs Q1 2022+2.3% vs Q4 2022
Net Income$50.70M−16.6% vs Q1 2022+225.0% vs Q4 2022
EPS Diluted$1.35−12.9% vs Q1 2022no prior Q4 2022 on file
Gross Profit$130,400,000−5.4%
Operating Income$103,900,000−12.7%
Operating Cash Flow$5,300,000−78.2%
Free Cash Flowderived-$20,100,000N/M
Margins · derived
Gross margin33.2%−2.8 pt vs Q1 2022
Operating margin26.5%−4.6 pt vs Q1 2022
Net margin12.9%−3.0 pt vs Q1 2022

What the release said

The release

Same quarter

MetricQ1 2023Q1 2022Q1 2021Q1 2020
Revenue$392.60M$382.80M$320.30M$288.20M
Net Income$50.70M$60.80M$48.70M$45.30M
EPS Diluted$1.35$1.55$1.20$1.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR